Contribution of glutamatergic systems in locus coeruleus to nucleus paragigantocellularis stimulation-evoked behavior

Pharmacology Biochemistry and Behavior

Volumn 63, Issue 4, 1999, Pages 555-567

  Liu, Niansen ^a   Ho, Ing Kang ^a   Rockhold, Robin William ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Glutamate; Kynurenic acid; L trans pyrrolidine 2,4 dicarboxylic acid; Locus coeruleus; Microdialysis; Nucleus paragigantocellularis; Opioid withdrawal

Indexed keywords

GLUTAMATE RECEPTOR; GLUTAMIC ACID; KYNURENIC ACID; PYRROLIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; ELECTROSTIMULATION; INTRACEREBRAL DRUG ADMINISTRATION; LOCUS CERULEUS; MALE; MICRODIALYSIS; NONHUMAN; PERFUSION; PRIORITY JOURNAL; RAT; WITHDRAWAL SYNDROME;

AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BASAL GANGLIA; BEHAVIOR, ANIMAL; DICARBOXYLIC ACIDS; ELECTRIC STIMULATION; ELECTRODES, IMPLANTED; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; KYNURENIC ACID; LOCUS COERULEUS; MALE; MICRODIALYSIS; NEUROTRANSMITTER UPTAKE INHIBITORS; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; STEREOTAXIC TECHNIQUES; STEREOTYPED BEHAVIOR;

CANIS FAMILIARIS;

EID: 0032764244     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(99)00005-2     Document Type: Article

References (53)

1. Aghajanian G.K. Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature. 276:1978;186-188.
2. Aghajanian G.K., Alreja M., Nestler E.J., Kogan J.H. Dual mechanisms of opiate dependence in the locus coeruleus. Clin. Neuropharmacol. 15(Suppl. 1PtA):1992;143A-144A.
3. Aghajanian G.K., Kogan J.H., Moghaddam B. Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus. An in vivo microdialysis study Brain Res. 636:1994;126-130.
4. Akaoka H., Aston-Jones G. Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory amino acid input. J. Neurosci. 11:1991;3830-3839.
5. Andrade R., VanderMaelen C.P., Aghajanian G.K. Morphine tolerance and dependence in the locus coeruleus. Single cell studies in brain slices Eur. J. Pharmacol. 91:1983;161-169.
6. Aston-Jones G., Ennis M., Pieribone V.A., Nickell W.T., Shipley M.T. The brain nucleus locus coeruleus. Restricted afferent control of a broad afferent network Science. 234:1986;734-736.
7. Aston-Jones G., Shipley M.T., Chouvet G., Ennis M., Van Bockstaele E.J., Pieribone V., Shiekhattar R., Akaoka H., Drolet G., Astier B., Charlety P., Valentino R., Williams J.T. Afferent regulation of locus coeruleus neurons. Anatomy, physiology and pharmacology Prog. Brian Res. 88:1991;47-75.
8. Baraban S.C., Stornetta R.L., Guyenet P.G. Effects of morphine and morphine withdrawal on adrenergic neurons of the rat rostral ventrolateral medulla. Brain Res. 675:1995;245-257.
9. Bloc A., Samuel D., Forni C., Dusicier N., Kerkerian-Le Goff L. Effects of ionotropic excitatory amino acid receptor antagonists on glutamate transport and transport-mediated changes in extracellular excitatory amino acids in the rat striatum. J. Neurochem. 64:1995;1598-1604.
10. Bozarth M.A. Opioid reinforcement processes. Rodgers R.J., Cooper S.J. Endorphins, opiates and behavioral processes. 1988;53 John Wiley and Sons, Ltd, New York.
11. Britton K.T., Svensson J., Schwartz J., Bloom F.E., Koob G.B. Dorsal noradrenergic bundle lesions fail to alter opiate withdrawal or suppression of opiate withdrawal by clonidine. Life Sci. 334:1984;133-139.
12. Calvino B., Lagowska J., Ben-Ari Y. Morphine withdrawal syndrome. Differential participation of structures located within the amygdaloid complex and striatum of the rat Brain Res. 177:1979;19-34.
13. Chieng B., Christie M.J. Lesions to terminals of noradrenergic locus coeruleus neurones do not inhibit opiate withdrawal behavior in the rat. Neurosci. Lett. 186:1995;37-40.
14. Christie M.J., Williams J.T., North R.A. Cellular mechanisms of opioid tolerance. Studies in single brain neurons Mol. Pharmacol. 32:1987;633-638.
15. Christie M.J., Williams J.T., Osborne P.B., Bellchambers C.E. Where is the locus in opioid withdrawal? Trends Pharmacol. 18:1997;134-140.
16. Dauge V., Rossignol P., Roques B.P. Comparison of the behavioural effects induced by administration in rat nucleus accumbens or nucleus caudatus of selective mu and delta opioid peptides or kelatorphan an inhibitor of enkephalin-degrading-enzymes. Psychopharmacology (Berlin). 96:1988;343-352.
17. Dauge V., Rossignol P., Roques B.P. Blockade of dopamine receptors reverses the behavioral effects of endogenous enkephalins in the nucleus caudatus but not in the nucleus accumbens. Differential involvement of delta and mu receptors Psychopharmacology (Berlin). 99:1989;168-175.
18. Delfs J.M., Druhan J.P., Aston-Jones G. Involvement of non-locus coeruleus (LC) projections in the expression of opiate withdrawal-induced conditioned place aversion (CPA). Soc. Neurosci. Abstr. 23:1997;1108.
19. Ellison D.W., Beal M.F., Martin J.B. Amino acid neurotransmitters in postmortem human brain analyzed by high performance liquid chromatography with electrochemical detection. J. Neurosci. Methods. 19:1987;305-315.
20. Ennis M., Aston-Jones G. Activation of locus coeruleus from nucleus paragigantocellularis. A new excitatory amino acid pathway in brain J. Neurosci. 8:1988;3644-3657.
21. Feng Y.Z., Zhang T., Rockhold R.W., Ho I.K. Increased locus coeruleus glutamate levels are associated with naloxone-precipitated withdrawal from butorphanol in the rat. Neurochem. Res. 20:1995;675-681.
22. Feng Y.Z., Zhang T., Tokuyama S., Zhu H., Rockhold R.W., Ho I.K. Mu and delta opioid receptor antagonists precipitate similar withdrawal phenomena in butorphanol and morphine dependence. Neurochem. Res. 21:1996;63-71.
23. Feng Y.Z., Rockhold R.W., Ho I.K. Norbinaltorphimine precipitates withdrawal and excitatory amino acid release in the locus coeruleus of butorphanol - but not morphine - dependent rats. J. Pharmacol. Exp. Ther. 283:1997;932-938.
24. Foote S.L., Bloom F.E., Aston-Jones G. Nucleus locus coeruleus. New evidence of anatomical and physiological specificity Physiol. Rev. 63:1983;844-914.
25. Hong M., Milne B., Jhamandas K. Evidence for the involvement of excitatory amino acid pathways in the development of precipitated withdrawal from acute and chronic morphine. An in vivo voltammetric study in the rat locus coeruleus Brain Res. 623:1993;131-141.
26. Hoshi K., Ma T.G., Ho I.K. Naloxone-precipitated κ-opioid receptor agonist withdrawal increases glutamate levels in rat locus coeruleus. Eur. J. Pharmacol. 314:1996;301-306.
27. Hoshi K., Ma T., Oh S., Ho I.K. Increased release of excitatory amino acids in rat locus coeruleus in κ-opioid agonist dependent rats precipitated by nor-binaltorphimine. Brain Res. 753:1997;63-68.
28. Jin C.-B., Rockhold R.W. Circulatory, baroreflex and renal responses to intracerebral kainic acid infusion in the conscious rat. J. Pharmacol. Exp. Ther. 251:1989;969-975.
29. Kogan J.H., Nestler E.J., Aghajanian G.K. Elevated basal firing rates and enhanced responses to 8-Br-cAMP in locus coeruleus neurons in brain slices from opiate-dependent rats. Eur. J. Pharmacol. 211:1992;47-53.
30. Koob G.F., Bloom F.F. Cellular and molecular mechanisms of drug dependence. Science. 242:1988;715-723.
31. Lada M.W., Vickroy T.W., Kennedy R.T. Evidence for neuronal origin and metabotropic receptor-mediated regulation of extracellular glutamate and aspartate in rat striatum in vivo following electrical stimulation of the prefrontal cortex. J. Neurochem. 70:1998;617-625.
32. Liu N., Rockhold R.W., Ho I.K. Electrical stimulation of nucleus paragigantocellularis induces opioid withdrawal-like behaviors in the rat. Pharmacol. Biochem. Behav. 62:1999;263-271.
33. Loewy A.D., Wallach J.H., McLellar S. Efferent connections of the ventral medulla oblongata in the rat. Brain Res. Rev. 3:1981;63-80.
34. Maldonado R., Koob G.F. Destruction of the locus coeruleus decreases physical signs of opiate withdrawal. Brain Res. 605:1993;128-138.
35. Maldonado R., Stinus L., Gold L.H., Koob G.F. Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J. Pharmacol. Exp. Ther. 261:1992;669-677.
36. Massieu L., Tapia R. Glutamate uptake impairment and neuronal damage in young and aged rats in vivo. J. Neurochem. 69:1997;1151-1160.
37. North R.A. Opioid actions on membrane ion channels. Herz A. Handbook of experimental pharmacology. 1993;773-797 Springer-Verlag, Berlin.
38. Paxinos G., Watson C. The rat brain in stereotoxic coordinates. 2nd ed:1986;Academic Press, Sydney.
39. Punch L.J., Self D.W., Nestler E.J., Taylor J.R. Opposite modulation of opiate withdrawal behaviors on microinfusion of a protein kinase A inhibitor versus activator into the locus coeruleus or periaqueductal gray. J. Neurosci. 17:1997;8520-8527.
40. Rasmussen K., Aghajanian G.K. Withdrawal-induced activation of locus coeruleus neurons in opiate-dependent rats. Attenuation by lesions of the nucleus paragigantocellularis Brain Res. 505:1989;346-350.
41. Rasmussen K., Beitner-Johnson D.B., Krystal J.H., Aghajanian G.K., Nestler E.J. Opiate withdrawal and the rat locus coeruleus. Behavioral, electrophysiological and biochemical correlates J. Neurosci. 10:1990;2308-2317.
42. Rasmussen K. Afferent effects on locus coeruleus in opiate withdrawal. Prog. Brain Res. 88:1991;207-216.
43. Rawls S.M., McGinty J.F. L-trans-Pyrrolidine-2,4-dicarboxylic acid-evoked striatal glutamate levels are attenuated by calcium reduction, tetrodotoxin, and glutamate receptor blockade. J. Neurochem. 68:1997;1553-1563.
44. Rawls S.M., McGinty J.F. κ Receptor activation attenuates L-trans-pyrrolidine-2,4-dicarboxylic acid-evoked glutamate levels in the striatum. J. Neurochem. 70:1998;626-634.
45. Rockhold R.W., Liu N., Sinchaisuk S., Ho I.K. Electrical stimulation of nucleus paragigantocellularis (PGi) and evocation of opioid withdrawal-like behavior. Naunyn Schmeidebergs Arch. Pharmacol. 358:1998;R178.
46. Roques B.P., Dauge V., Gacel G., Fournie-Zalusk M.C. Selective agonists and antagonists of delta opioid receptors and inhibitors of enkephalin metabolism. Potential use in treatment of mental illness Shagass C., Josiassen R.C., Bridger W.H., Weiss K.J., Staff D., Simpson G.M. Developments in psychiatry, Vol. 7, biological psychiatry 1985. 1985;287-289 Elsevier, New York.
47. Semba J., Kito S., Toru M. Characterization of extracellular amino acids in striatum of freely moving rats by in vivo microdialysis. J. Neural Transm. 100:1995;39-52.
48. Stinus L., Peron A., Reneric J.P., Cador M., Koob G.B. In morphine dependent rats, the total lesion of locus coeruleus norepinephrine neurons does not impair naloxone-induced withdrawal syndrome and conditioned place aversion, or the protective effects of clonidine upon opiate withdrawal. Soc. Neurosci. Abstr. 23:1997;1108.
49. Valentino R.J., Aston-Jones G. Physiological and anatomical determinants of locus coeruleus discharge. Bloom F.E., Kupfer D.J. Psychopharmacology. The fourth generation of progress:1995;373-385 Raven Press, Ltd, New York.
50. Valentino R.J., Wehby R.G. Morphine effects on locus coeruleus neurons are dependent on the state of arousal and availability of external stimuli. Studies in anesthetized and unanesthetized rats J. Pharmacol. Exp. Ther. 244:1988;1178-1186.
51. Wei E., Loh H.H., Way E.L. Quantitative aspects of precipitated abstinence in morphine-dependent rats. J. Pharmacol. Exp. Ther. 184:1973;398-403.
52. Zhang T., Feng Y., Rockhold R.W., Ho I.K. Naloxone-precipitated morphine withdrawal increases pontine glutamate levels in the rat. Life Sci. 55:1994;25-31. PL.
53. Zhu H., Rockhold R.W., Ho I.K. The role of glutamate in physical dependence on opioids. Jpn. J. Pharmacol. 76:1998;1-14.